Concepedia

Jumpei Kiyokawa

JK

Statistics

Publications

5

Citations

210

H-Index

5

Active since

2009

Affiliations

JW Pharmaceutical (South Korea)(Current)

Shin Nippon Biomedical Laboratories (Japan)

Jumpei Kiyokawa is an author at JW Pharmaceutical (South Korea) specializing in cell biology, life sciences, and transporters.

Publications per year

2009–2019

5

Publications

5

Electrophysiological Characterization of Cardiomyocytes Derived From Human Induced Pluripotent Stem Cells

Masaki Honda, Jumpei Kiyokawa, Mitsuyasu Tabo et al. · Journal of Pharmacological Sciences · 2011 · 81 citations · Full text

, , +12

Stronger Uricosuric Effects of the Novel Selective URAT1 Inhibitor UR-1102 Lowered Plasma Urate in Tufted Capuchin Monkeys to a Greater Extent than Benzbromarone

Sung-Shin Ahn, S. Ohtomo, Jumpei Kiyokawa et al. · Journal of Pharmacology and Experimental Therapeutics · 2016 · 61 citations

, , +17

Modulation of retinal capillary endothelial cells by Müller glial cell-derived factors.

Hayato Abukawa, Masatoshi Tomi, Jumpei Kiyokawa et al. · PubMed · 2009 · 35 citations

, , +13

Collagen vitrigel promotes hepatocytic differentiation of induced pluripotent stem cells into functional hepatocyte-like cells

Shun Nakai, Ima Shibata, Takahiro Shitamichi et al. · Biology Open · 2019 · 23 citations · Full text

, , +17

SAT0356 The Therapeutic Efficacy of the Novel Uricosuric Agent UR-1102 for Hyperuricemia and Gout

Sung-Shin Ahn, Naoshi Horiba, S. Ohtomo et al. · Annals of the Rheumatic Diseases · 2013 · 10 citations

, , +17

1–5 of 5